Caris Life Sciences vs Cellcolabs
Caris Life Sciences vs Cellcolabs, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Caris Life Sciences is on 59/100 and Cellcolabs on 55/100.
Where each one leads
Caris Life Sciences
- our overall score: 59/100 against 55/100
- agent readiness: 47/100 against 40/100
- domain rating: 63/100 against 37/100
- headcount: 1,659 against 79
- funding raised: $700M against $15.5M
- LinkedIn following: 77,698 against 6,563
Cellcolabs
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Caris Life Sciences | Cellcolabs |
|---|---|---|
| What it is | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. | AI-powered platform for personalized cell therapy development and manufacturing. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2008 | 2021 |
| Headquarters | Irving, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Caris Life Sciences | Cellcolabs |
|---|---|---|
| Employees | 1,659 | 79 |
| Total funding | $700M | $15.5M |
| Latest round | Series D | Not published |
| Valuation | $7.8B | Not published |
| LinkedIn followers | 77,698 | 6,563 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Caris Life Sciences | Cellcolabs |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 55/100 |
| Traction | 60/100 | Not published |
| Search visibility | 22/100 | 2/100 |
| Quality | 78/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (47/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 63/100 | 37/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Caris Life Sciences | Cellcolabs |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Not detected |
| Analytics | Google Tag Manager | Google Tag Manager |
Caris Life Sciences vs Cellcolabs: common questions
Which is better, Caris Life Sciences or Cellcolabs?
On our 0-100 score Caris Life Sciences rates higher (59/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Caris Life Sciences and Cellcolabs compare on the numbers?
Caris Life Sciences leads on our overall score (59/100 against 55/100), agent readiness (47/100 against 40/100), domain rating (63/100 against 37/100), headcount (1,659 against 79), funding raised ($700M against $15.5M), LinkedIn following (77,698 against 6,563).
Read the full Caris Life Sciences review and pricing or the Cellcolabs review and pricing. You can also browse other Caris Life Sciences alternatives we track.